{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:40:27Z","timestamp":1768869627439,"version":"3.49.0"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":89,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1002\/jcsm.12047","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T14:58:51Z","timestamp":1433429931000},"page":"343-350","source":"Crossref","is-referenced-by-count":36,"title":["Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib"],"prefix":"10.1002","volume":"6","author":[{"given":"Fr\u00e9d\u00e9rick","family":"Moryoussef","sequence":"first","affiliation":[{"name":"Department of Gastro-Enterology and Digestive Oncology; CHU Reims, H\u00f4pital Robert-Debr\u00e9; 51092 Reims France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Dhooge","sequence":"additional","affiliation":[{"name":"Department of Gastro-Enterology, Cochin Teaching Hospital, AP-HP; Universit\u00e9\u00b4 Paris Descartes; Sorbonne Paris Cite Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Volet","sequence":"additional","affiliation":[{"name":"Department of Gastro-Enterology and Digestive Oncology; CHU Reims, H\u00f4pital Robert-Debr\u00e9; 51092 Reims France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coralie","family":"Barbe","sequence":"additional","affiliation":[{"name":"Department of Gastro-Enterology, Cochin Teaching Hospital, AP-HP; Universit\u00e9\u00b4 Paris Descartes; Sorbonne Paris Cite Paris France"},{"name":"Clinical Research Unit; CHU Reims, H\u00f4pital Robert-Debr\u00e9; 51092 Reims France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Brezault","sequence":"additional","affiliation":[{"name":"Department of Gastro-Enterology, Cochin Teaching Hospital, AP-HP; Universit\u00e9\u00b4 Paris Descartes; Sorbonne Paris Cite Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Hoeffel","sequence":"additional","affiliation":[{"name":"Department of Radiology; CHU Reims, H\u00f4pital Robert-Debr\u00e9; 51092 Reims France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[{"name":"Department of Gastro-Enterology, Cochin Teaching Hospital, AP-HP; Universit\u00e9\u00b4 Paris Descartes; Sorbonne Paris Cite Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[{"name":"Department of Gastro-Enterology and Digestive Oncology; CHU Reims, H\u00f4pital Robert-Debr\u00e9; 51092 Reims France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"10.1002\/jcsm.12047-BIB0001|jcsm12047-cit-0001","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1002\/jcsm.12047-BIB0002|jcsm12047-cit-0002","first-page":"vii49","article-title":"Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"ESMO \/ European Sarcoma Network Working Group","year":"2012","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"10.1002\/jcsm.12047-BIB0003|jcsm12047-cit-0003","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/jcsm.12047-BIB0004|jcsm12047-cit-0004","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MCO.0b013e32831cef61","article-title":"Inflammatory burden and amino acid metabolism in cancer cachexia","volume":"12","author":"Durham","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1002\/jcsm.12047-BIB0005|jcsm12047-cit-0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1002\/jcsm.12047-BIB0006|jcsm12047-cit-0006","first-page":"491","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients","volume":"69","author":"Dewys","year":"1980","journal-title":"Eastern Cooperative Oncology Group Am J Med"},{"key":"10.1002\/jcsm.12047-BIB0007|jcsm12047-cit-0007","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10637-013-0053-6","article-title":"Low skeletal muscle is associated with toxicity in patients included in phase I trials","volume":"32","author":"Cousin","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1002\/jcsm.12047-BIB0008|jcsm12047-cit-0008","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SPC.0000000000000011","article-title":"Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer","volume":"7","author":"Antoun","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1002\/jcsm.12047-BIB0009|jcsm12047-cit-0009","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1002\/jcsm.12047-BIB0010|jcsm12047-cit-0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00280-010-1288-y","article-title":"An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity","volume":"67","author":"Prado","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/jcsm.12047-BIB0011|jcsm12047-cit-0011","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcsm.12047-BIB0012|jcsm12047-cit-0012","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1002\/jcsm.12047-BIB0013|jcsm12047-cit-0013","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcsm.12047-BIB0014|jcsm12047-cit-0014","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer","volume":"66","author":"Barret","year":"2014","journal-title":"Nutr Cancer"},{"key":"10.1002\/jcsm.12047-BIB0015|jcsm12047-cit-0015","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000061","article-title":"Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib","author":"Cushen","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1002\/jcsm.12047-BIB0016|jcsm12047-cit-0016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000342763","article-title":"Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis","volume":"84","author":"Dhooge","year":"2013","journal-title":"Oncology"},{"key":"10.1002\/jcsm.12047-BIB0017|jcsm12047-cit-0017","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.28798","article-title":"Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality","volume":"120","author":"Psutka","year":"2014","journal-title":"Cancer"},{"key":"10.1002\/jcsm.12047-BIB0018|jcsm12047-cit-0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"key":"10.1002\/jcsm.12047-BIB0019|jcsm12047-cit-0019","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1002\/jcsm.12047-BIB0020|jcsm12047-cit-0020","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.58","article-title":"Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients","volume":"108","author":"Huillard","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1002\/jcsm.12047-BIB0021|jcsm12047-cit-0021","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1002\/jcsm.12047-BIB0022|jcsm12047-cit-0022","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1002\/jcsm.12047-BIB0023|jcsm12047-cit-0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1002\/jcsm.12047-BIB0024|jcsm12047-cit-0024","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1002\/jcsm.12047-BIB0025|jcsm12047-cit-0025","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcsm.12047-BIB0026|jcsm12047-cit-0026","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpainsymman.2011.09.010","article-title":"Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study","volume":"44","author":"Dalal","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1002\/jcsm.12047-BIB0027|jcsm12047-cit-0027","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00330-014-3110-4","article-title":"Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer","volume":"24","author":"Yip","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1002\/jcsm.12047-BIB0028|jcsm12047-cit-0028","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1002\/jcsm.12047-BIB0029|jcsm12047-cit-0029","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1078-0432.CCR-06-2307","article-title":"Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome","volume":"13","author":"Acharyya","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcsm.12047-BIB0030|jcsm12047-cit-0030","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jcp.23029","article-title":"Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients","volume":"227","author":"Ciarcia","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1002\/jcsm.12047-BIB0031|jcsm12047-cit-0031","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study","volume":"28","author":"Antoun","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcsm.12047-BIB0032|jcsm12047-cit-0032","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13539-013-0113-y","article-title":"A pilot study of temsirolimus and body composition","volume":"4","author":"Veasey-Rodrigues","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12047-BIB0033|jcsm12047-cit-0033","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2012.144","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma","volume":"106","author":"Prado","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1002\/jcsm.12047-BIB0034|jcsm12047-cit-0034","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/17425255.4.2.137","article-title":"Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing","volume":"4","author":"Kacevska","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1002\/jcsm.12047-BIB0035|jcsm12047-cit-0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0007114512001067","article-title":"Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia","volume":"109","author":"Di Sebastiano","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1002\/jcsm.12047-BIB0036|jcsm12047-cit-0036","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1002\/jcsm.12047-BIB0037|jcsm12047-cit-0037","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13539-014-0156-8","article-title":"Sarcopenia: describing rather than defining a condition","volume":"5","author":"Alchin","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12047-BIB0038|jcsm12047-cit-0038","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13539-014-0149-7","article-title":"Are we closer to having drugs to treat muscle wasting disease?","volume":"5","author":"Morley","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1002\/jcsm.12047-BIB0039|jcsm12047-cit-0039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: impact, mechanisms and emerging treatments","volume":"4","author":"Vaughan","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcsm.12047","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcsm.12047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:49:32Z","timestamp":1625312972000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcsm.12047"}},"subtitle":["Sarcopenia predicts toxicities in patients with GIST"],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/jcsm.12047","archive":["Portico"],"relation":{},"ISSN":["2190-5991"],"issn-type":[{"value":"2190-5991","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}